Co-head research, Ashmore Investment
Minister of State for Finance, GoI
Sun Pharma : Imatinib Mesylate Is Therapeutic Equivalent To Gleevec
Sun Pharma : Launches Imatinib Mesylate In US
Balaji Tele : To Mull Fundraising Via Issue Of Securities On Pref Basis On February 4
The company has robust capex plans of around Rs 6300 crore for FY17. Both the Mumbai and Visakhapat...
There has been an earnings de-growth in rupee terms in FY16 but quantitatively Bodal Chemicals has d...
For the past five years the telecom business has been growing at around 28 percent year on year and ...
Chennai floods had a negative impact on Take. The company lost USD 160,000 in revenues in the third ...
A robust pipeline as well recent acquisition of US IT solutions company IBIS will aid growth in FY17...